Platelet parameters in COVID-19 infectio
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2023/06/054501
- Lead Sponsor
- Rashmi Jain Gupta
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients admitted to Lok Nayak Hospital who were diagnosed with COVID-19 during the period of study from 15 April to 15 May 2021 and from 4 January to 4 February 2022.
Exclusion Criteria
Patients whose platelet parameters were not done.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link platelet parameters to severe outcomes in CTRI/2023/06/054501 Coronavirus disease?
How do platelet indices correlate with viral load in SARS-CoV-2 infections compared to other coronaviruses?
What biomarkers of platelet function predict clinical deterioration in CTRI/2023/06/054501 patients with B972- Coronavirus disease?
Are there specific platelet-related adverse events associated with CTRI/2023/06/054501 observational study on B972- Coronavirus disease?
What therapeutic strategies targeting platelet activation are being explored for CTRI/2023/06/054501 Coronavirus disease patients?